Watch our capabilities presentation to learn how our integrated CDMO solutions accelerate immune cell therapy development from early-phase to commercial readiness.
This webinar explores how integrated PD/AD expertise can deliver robust, regulatory-ready assays and accelerates cell therapy development.
Kincell Bio Inc., a cell therapy contract development and manufacturing organization, today announced the signing of a memorandum of understanding with the Duke University School...
For cell therapy developers, early-phase speed without a clear CMC roadmap is extremely risky; however, overengineering early-phase work is too slow and costly. The programs...
This webinar explores how integrated PD/AD expertise can deliver robust, regulatory-ready assays and accelerates cell therapy development.
For cell therapy developers, early-phase speed without a clear CMC roadmap is extremely risky; however, overengineering early-phase work is too slow and costly. The programs...
Read NowBehind every milestone in cell and gene therapy is a human story that gives purpose to scientific progress.
Watch the discussion to see how cross-industry collaboration is redefining scalability, accessibility, and impact in cell and gene therapy.
Watch the video to experience the energy, ideas, and collaboration that made this gathering such a powerful moment for the field.
Explore how disciplined analytics accelerate every stage of cell therapy development. Our infographic traces the escalating rigor from exploring feasibility in preclinical studies to fully...
Learn More
1622 NW 55th Place
Gainesville, FL 32653
20 TW Alexander Dr, Suite 130
RTP, NC 27713
